
Monocobal-GB Tablet
Marketer
Captab Biotec
Salt Composition
Gabapentin (300mg) + Methylcobalamin (500mcg)
Overview Monocobal-GB Tablet
Neuropathic pain is treated with the combined medication, Cobal-GB tablets. These tablets alleviate pain by regulating nerve cell calcium channel function. Cobal-GB tablets are administered orally, with or without food, ideally before sleep. Consistent daily dosing, at the same time, ensures stable blood levels. Always adhere to your physician's prescribed dosage and duration. If a dose is missed, take it immediately upon recollection. Complete the prescribed course, even with symptom improvement. Abrupt cessation requires prior consultation with your doctor. Nausea, peripheral swelling, gait instability, blurred vision, fever, and involuntary eye movements (nystagmus) are potential side effects. Drowsiness and dizziness may occur; avoid activities requiring concentration until the drug's effects are known. Report any unusual mood shifts, new or worsening depression, or suicidal ideation to your physician. Inform your physician of pregnancy, pregnancy plans, or breastfeeding before commencing treatment. While generally compatible with other medications, interactions exist with certain drugs (including antacids and alcohol), potentially increasing adverse effects.
Primary Ingredients of Monocobal-GB Tablet
No text provided to rephrase.
Uses of Monocobal-GB Tablet
Managing neuropathic pain
Major Benefits of Monocobal-GB Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Monocobal-GB Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Monocobal-GB Tablet:
- Dizziness
- Sleepiness
- Tiredness
How to use Monocobal-GB Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Monocobal-GB Tablets can be consumed with or without food, however, consistent timing is recommended.
How Monocobal-GB Tablet works:
Monocobal-GB tablets contain gabapentin and methylcobalamin, working synergistically to alleviate neuropathic pain. Gabapentin, an alpha-2-delta ligand, reduces pain signals by influencing nerve cell calcium channels. Methylcobalamin, a B vitamin, supports myelin production, protecting and repairing nerve fibers. This combined action provides effective relief from nerve damage-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Monocobal-GB tablets and alcohol may induce pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Monocobal-GB Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Monocobal-GB Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Monocobal-GB Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Monocobal-GB Tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Monocobal-GB Tablet use in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Monocobal-GB Tablet :
Should you forget to take a Monocobal-GB Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Monocobal-GB Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience (Central Nervous System) |
